Chì significà "Clear"?
L'animali ùn porta micca a mutazione. Ùn svilupperà micca a malatia è ùn la trasmetterà.
Discover the importance of the DNA test for Congenital Methemoglobinemia Variant 1 (CM1) in dogs, a genetic disorder affecting oxygen transport in the blood. Early detection through this test helps breeders and veterinarians identify carriers and affected dogs, ensuring healthier breeding decisions. By screening for CM1, you can prevent the inheritance of this serious condition, improving your dog's quality of life. Our accurate and reliable DNA test provides quick results, making it an essential tool for responsible dog breeding. Protect your furry friend’s health with the CM1 DNA test today. Stay informed and promote genetic wellness in your canine companions.
Congenital Methemoglobinemia Variant 1 (CM1) in dogs is a genetic disorder that affects the blood's ability to carry oxygen efficiently. This condition is caused by mutations in specific genes responsible for hemoglobin function. A DNA test can identify carriers and affected dogs, helping breeders make informed decisions. Early detection through testing is crucial to prevent passing the disorder to offspring. Managing CM1 improves the health and quality of life for affected dogs.
Questa prova di DNA hè inclusa partendu da u nostru pacchettu Basic — è hè ancu parte di i pacchetti Basic, Standard, Advanced, Complete.
Vede i pacchetti di test di DNA →Congenital Methemoglobinemia Variant 1 (CM1) is a genetic disorder that affects the ability of hemoglobin in red blood cells to carry oxygen effectively. This condition is caused by mutations in the gene responsible for producing an enzyme known as cytochrome b5 reductase, which plays a crucial role in maintaining hemoglobin in its functional state. In affected dogs, the inability to reduce methemoglobin back to its oxygen-carrying form leads to a range of clinical symptoms.
Dogs with CM1 may exhibit a variety of clinical signs, primarily due to the reduced oxygen-carrying capacity of their blood. Common symptoms include cyanosis, which is a bluish tint to the gums and mucous membranes, lethargy, weakness, and exercise intolerance. In severe cases, affected dogs can experience respiratory distress, increased heart rate, and even collapse. The severity of symptoms can vary depending on the extent of the condition and the individual dog's health.
Diagnosis of CM1 is typically based on clinical signs and a thorough evaluation of the dog's medical history. A veterinarian may perform blood tests to check for elevated levels of methemoglobin. However, a definitive diagnosis is often achieved through genetic testing, which can identify specific mutations associated with the CM1 condition. This testing allows for early identification of affected individuals and enables informed breeding decisions to minimize the prevalence of the disorder.
While there is currently no cure for CM1, management strategies focus on alleviating symptoms and improving the quality of life for affected dogs. This may include providing supplemental oxygen during periods of distress, avoiding strenuous activities, and ensuring a stress-free environment. In some cases, medications such as methylene blue may be administered under veterinary guidance to help reduce methemoglobin levels, although this treatment is not universally effective and should be used cautiously.
Congenital Methemoglobinemia Variant 1 (CM1) is a serious genetic condition that can significantly impact a dog's health and well-being. Early diagnosis through DNA testing and appropriate management strategies are essential for improving outcomes for affected dogs. Continued research and education about CM1 can help pet owners and breeders make informed decisions to better understand and address this condition.
L'animali ùn porta micca a mutazione. Ùn svilupperà micca a malatia è ùn la trasmetterà.
No. L'animali hè generalmente sanu, ma pò trasmette a mutazione à u so prole.
Porta duie copie mutate. I segni clinichi sò previsti secondu a malatia. Ùn deve esse criatu.
Alcune malatie sò ligati à u sessu, cusì a so espressione varieghja secondu u sessu di l'animali.
This DNA test detects the mutation associated with Congenital Methemoglobinemia Variant 1 (CM1) in order to identify clear, carrier, or at-risk animals.
A prova di DNA aiuta i criatori à pianificà accoppiamenti più sicuri è riduce u risicu di trasmette a mutazione à a prole.
U modu di eredità rappurtatu per questa prova hè Autosomal Recessive.
This test analyses the mutation CYB5R3 c.580A>C.
Micca necessariamente. L'interpretazione dipende da u mudellu di eredità è u genotipu resultanti.
Shino H, OtsukaYamasaki Y, Sato T, Ooi K, Inanami O, Sato R, Yamasaki M. Familial Congenital Methemoglobinemia in Pomeranian Dogs Caused by a Missense Variant in the NADH-Cytochrome B5 Reductase Gene. J Vet Intern Med. 2018 Jan;32(1):165-171. doi: 10.1111/jvim.15031. Epub 2018 Jan 22.
A vostra privacy, a vostra scelta
Utilizemu i cookies essenziali per eseguisce u situ web. I cookies opzionali (cum'è i fornituri di cuntenutu incrustati) sò disattivati per difettu è sò attivati solu s'è vo avete d'accordu. Pudete cambià a vostra scelta in ogni mumentu cù u buttone "Cookies".
Ubligatoriu per e funzioni core è a sicurità. Sempre attivatu.
Migliora e funzioni cum'è u salvamentu di preferenza o l'incrustazioni senza publicità.
Ci aiuta à capisce l'usu di u situ. Disabilitatu per difettu.
Publicità / seguimentu à traversu i siti (alcuni video / carte incrustate). Disabilitatu per difettu.